<DOC>
<DOCNO>
EP-0007412
</DOCNO>
<TEXT>
<DATE>
19800206
</DATE>
<IPC-CLASSIFICATIONS>
C07D-233/00 <main>A61K-31/415</main> A61P-9/00 A61P-9/10 C07D-233/50 A61K-31/415 
</IPC-CLASSIFICATIONS>
<TITLE>
utilisation of 2-(n-(2,6-dichloro-phenyl)-n-allyl-amino)-imidazoline-(2) for the production of bradycardiac drugs.
</TITLE>
<APPLICANT>
boehringer sohn ingelheimde <sep>c.h. boehringer sohn<sep>c.h. boehringer sohn postfach 200 d-6507 ingelheim am rheinde<sep>c.h. boehringer sohn<sep>
</APPLICANT>
<INVENTOR>
arndts dietrich dr<sep>kobinger walter prof dr<sep>koppe herbert dr<sep>kummer werner dr<sep>lillie christian dr<sep>pichler ludwig dr<sep>stahle helmut dr<sep>arndts, dietrich, dr.<sep>kobinger, walter, prof. dr.<sep>koppe, herbert, dr.<sep>kummer, werner, dr.<sep>lillie, christian, dr.<sep>pichler, ludwig, dr.<sep>stahle, helmut, dr.<sep>arndts, dietrich, dr.mühlstrasse 7d-6531 appenheimde<sep>kobinger, walter, prof. dr.belghofergasse 27a-1120 wienat<sep>köppe, herbert, dr.neuweg 72d-6507 ingelheimde<sep>kummer, werner, dr.georg-scheuing-strasse 15d-6507 ingelheimde<sep>lillie, christian, dr.hansi-niese-weg 12a-1130 wienat<sep>pichler, ludwig, dr.gusshausstrasse 24a-1040 wienat<sep>stähle, helmut, dr.rotweinstrasse 23d-6507 ingelheimde<sep>arndts, dietrich, dr.<sep>kobinger, walter, prof. dr.<sep>koppe, herbert, dr.<sep>kummer, werner, dr.<sep>lillie, christian, dr.<sep>pichler, ludwig, dr.<sep>stahle, helmut, dr.<sep>arndts, dietrich, dr. mühlstrasse 7d-6531 appenheimde <sep>kobinger, walter, prof. dr. belghofergasse 27 a-1120 wienat<sep>köppe, herbert, dr.neuweg 72d-6507 ingelheimde<sep>kummer, werner, dr.georg-scheuing-strasse 15d-6507 ingelheimde<sep>lillie, christian, dr.hansi-niese-weg 12a-1130 wienat<sep>pichler, ludwig, dr.gusshausstrasse 24a-1040 wienat<sep>stähle, helmut, dr.rotweinstrasse 23d-6507 ingelheimde<sep>
</INVENTOR>
<ABSTRACT>
The invention relates to the use of 2 [N- (2,6-dichlorophenyl) -N-allyl-amino] -imidazolin- (2) and its acid addition salts for lowering the heart rate.The active ingredient is preferably administered in a single dose of 5 to 50 mg.
</ABSTRACT>
</TEXT>
</DOC>
